Discover molecular disease subtypes from multidimensional data and assign new samples into them with confidence — powered by the RNA1 foundation model, which carries published subtypings across new samples and surfaces novel molecular subtypes where the literature has none.
Disease subtypes don’t emerge from a single dimension. Combine bulk and single-cell omics, clinical data, and prior knowledge to identify cohesive molecular subtypes and the features that define them.
Once a subtype model is built, assign new samples into the right subtype with a trained classifier — and immediately see which clinical, molecular and outcome features differ between groups.
Subtypes feed straight into Predictive Modeling and Clinical Trial Analysis — so a subtype hypothesis can become a stratification strategy in the same session.
Walk through this solution with an applications scientist — focused on the questions that matter to you.